ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 579,48
-0,70%
Dow Jones
40 211,72
0,53%
DAX
18 485,26
-0,62%
Brent Oil
83,585
-0,90%
Bitcoin
62 748,51
-3,24%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
09/06/202311h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at EHA and ICMLLSE:0J7GHutchison China Meditech Ltd
06/06/202311h00UK RegulatoryHutchmed (China) Limited LTIP and Share Option SchemeLSE:0J7GHutchison China Meditech Ltd
31/05/202310h30UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
26/05/202308h00UK RegulatoryHutchmed (China) Limited Fruquintinib NDA Granted Priority Review by FDALSE:0J7GHutchison China Meditech Ltd
26/05/202308h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at ASCO 2023LSE:0J7GHutchison China Meditech Ltd
17/05/202310h30UK RegulatoryHutchmed (China) Limited Standard form for notification of major holdingsLSE:0J7GHutchison China Meditech Ltd
12/05/202314h15UK RegulatoryHutchmed (China) Limited Annual General Meeting Poll ResultsLSE:0J7GHutchison China Meditech Ltd
12/05/202310h30UK RegulatoryHutchmed (China) Limited Board of Directors and Board Committee MembershipLSE:0J7GHutchison China Meditech Ltd
10/05/202310h30UK RegulatoryHutchmed (China) Limited Appointment of Independent NEDLSE:0J7GHutchison China Meditech Ltd
21/04/202310h30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPLSE:0J7GHutchison China Meditech Ltd
18/04/202308h00RNS Non-RegulatoryHutchmed (China) Limited NDA Acceptance in China for FruquintinibLSE:0J7GHutchison China Meditech Ltd
12/04/202308h00RNS Non-RegulatoryHutchmed (China) Limited Presentations at AACR Annual Meeting 2023LSE:0J7GHutchison China Meditech Ltd
11/04/202310h30UK RegulatoryHutchmed (China) Limited 2022 Annual Report and Notice of AGMLSE:0J7GHutchison China Meditech Ltd
11/04/202310h30UK RegulatoryHutchmed (China) Limited Intended Retirement of Independent NEDLSE:0J7GHutchison China Meditech Ltd
04/04/202311h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Registration Phase EnrollmentsLSE:0J7GHutchison China Meditech Ltd
31/03/202308h00RNS Non-RegulatoryHutchmed (China) Limited Rolling Submission of Fruquintinib US NDA CompleteLSE:0J7GHutchison China Meditech Ltd
14/03/202314h30RNS Non-RegulatoryHutchmed (China) Limited Closing of Fruquintinib License to TakedaLSE:0J7GHutchison China Meditech Ltd
08/03/202309h30UK RegulatoryHutchmed (China) Limited Director's Share DealingLSE:0J7GHutchison China Meditech Ltd
28/02/202313h15RNS Non-RegulatoryHutchmed (China) Limited Publication of Form 20-FLSE:0J7GHutchison China Meditech Ltd
28/02/202309h30UK RegulatoryHutchmed (China) Limited 2022 Full Year Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
27/02/202311h00RNS Non-RegulatoryHutchmed (China) Limited Enrollment Completed in Phase 2 Amdizalisib trialLSE:0J7GHutchison China Meditech Ltd
31/01/202309h30UK RegulatoryHutchmed (China) Limited Notice of ResultsLSE:0J7GHutchison China Meditech Ltd
23/01/202309h00UK RegulatoryHutchmed (China) Limited License to Takeda for Fruquintinib outside ChinaLSE:0J7GHutchison China Meditech Ltd
18/01/202315h30UK RegulatoryHutchmed (China) Limited Inclusion of ORPATHYS in NRDL in ChinaLSE:0J7GHutchison China Meditech Ltd
03/01/202309h30RNS Non-RegulatoryHutchmed (China) Limited Enrollment Completed in Phase 3 TrialLSE:0J7GHutchison China Meditech Ltd
30/12/202209h30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
19/12/202211h00RNS Non-RegulatoryHutchmed (China) Limited FDA NDA Rolling Submission for FruquintinibLSE:0J7GHutchison China Meditech Ltd
15/11/202208h00UK RegulatoryHutchmed (China) Limited HUTCHMED Announces Strategy UpdateLSE:0J7GHutchison China Meditech Ltd
14/11/202208h00UK RegulatoryHutchmed (China) Limited Positive Topline Phase 3 Result in FruquintinibLSE:0J7GHutchison China Meditech Ltd
27/10/202213h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase 2/3 Trial of FruquintinibLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

EU
AF
Air FranceKLM
EU
BN
Danone
EU
LR
Legrand
EU
BNP
BNP Paribas
NASDAQ
NVDA
NVIDIA
NASDAQ
GOOGL
Alphabet
EU
HO
Thales
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
EU
ORA
Orange
EU
ACA
Credit Agricole
EU
PX1
CAC 40
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés